Gossamer Bio GOSS
NASDAQ GOSS
$0.16 -0.02 (-11.23%)
At close: Sep 9, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Net Shares Issued and Repurchased (2018 - 2020)

Gossamer Bio (GOSS) posted Net Shares Issued and Repurchased of $1.7 million for Q1 2020, down 58.87% on a QoQ basis from $4.2 million in Q4 2019, and down 27.82% year-over-year from $2.4 million in Q2 2019.

Analysis

Gossamer Bio (GOSS) Net Shares Issued and Repurchased (2018 - 2020) Analysis & Trends

Gossamer Bio has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at $1.7 million in Q1 2020.

  • On a quarterly basis, Net Shares Issued and Repurchased fell 27.82% year-over-year to $1.7 million in Q1 2020; TTM through Mar 2020 was $1.7 million, a 27.82% decrease from a year earlier, with the FY2019 full-year figure at $4.2 million, down 18.45% from the prior year.
  • Net Shares Issued and Repurchased was $1.7 million for Q1 2020 at Gossamer Bio, down from $4.2 million in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $5.1 million in Q4 2018, with the low at $1.7 million in Q1 2020.
  • Average Net Shares Issued and Repurchased over 3 years is $3.4 million, with a median of $3.3 million recorded in 2019.
  • The sharpest annual moves came in 2019 and 2020: Net Shares Issued and Repurchased retreated 18.45% in 2019, then declined 27.82% in 2020.
  • Over 3 years, Net Shares Issued and Repurchased stood at $5.1 million in 2018, then dropped by 18.45% to $4.2 million in 2019, then slumped by 58.87% to $1.7 million in 2020.
  • The last three Net Shares Issued and Repurchased figures came in at $1.7 million (Q1 2020), $4.2 million (Q4 2019), and $2.4 million (Q1 2019), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -3.07 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
10 Gossamer Bio 57.60 Mn 576,568.19 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 1.73 Mn
Dec 31, 2019 4.19 Mn
Mar 31, 2019 2.39 Mn
Dec 31, 2018 5.14 Mn